{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:04:01Z","timestamp":1785135841791,"version":"3.55.0"},"reference-count":15,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["IJU Case Reports"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Lenvatinib plus pembrolizumab is a standard first\u2010line therapy for advanced renal cell carcinoma (RCC), and acute acalculous cholecystitis is a rare adverse event.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation<\/jats:title>\n                    <jats:p>A 60\u2010year\u2010old woman with metastatic TFE3\u2010positive non\u2013clear cell RCC, classified as poor risk by the International Metastatic RCC Database Consortium (IMDC) criteria, started pembrolizumab plus lenvatinib after palliative radiotherapy for cervical spine metastasis. Lenvatinib was initiated at 8\u2009mg and escalated to 12\u2009mg, achieving tumor shrinkage. Nine days after starting cycle 4, she developed fever and right upper quadrant pain. Computed tomography demonstrated gallbladder distension and wall thickening without gallstones, consistent with acute acalculous cholecystitis. Lenvatinib was interrupted, and intravenous piperacillin\/tazobactam was administered; her symptoms improved without drainage. Lenvatinib was resumed at 8\u2009mg with pembrolizumab, and no recurrence occurred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early recognition and temporary interruption of lenvatinib with antibiotics may allow cautious rechallenge.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/iju5.70203","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:15:04Z","timestamp":1780121704000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Case of Acalculous Cholecystitis During Lenvatinib Plus Pembrolizumab Therapy for Advanced Renal Cell Carcinoma"],"prefix":"10.1002","volume":"9","author":[{"given":"Erika","family":"Soga","sequence":"first","affiliation":[{"name":"Department of Urology Yokohama City University Graduate School of Medicine  Yokohama Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-0391","authenticated-orcid":false,"given":"Go","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Urology Yokohama City University Graduate School of Medicine  Yokohama Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Urology Yokohama City University Graduate School of Medicine  Yokohama Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rio","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Urology Yokohama City University Graduate School of Medicine  Yokohama Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3446-6293","authenticated-orcid":false,"given":"Ryosuke","family":"Jikuya","sequence":"additional","affiliation":[{"name":"Department of Urology Yokohama City University Graduate School of Medicine  Yokohama Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Tatenuma","sequence":"additional","affiliation":[{"name":"Department of Urology Yokohama City University Graduate School of Medicine  Yokohama Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0744-7492","authenticated-orcid":false,"given":"Mitsuru","family":"Komeya","sequence":"additional","affiliation":[{"name":"Department of Urology Yokohama City University Graduate School of Medicine  Yokohama Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4433-370X","authenticated-orcid":false,"given":"Hiroki","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Urology Yokohama City University Graduate School of Medicine  Yokohama Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Hasumi","sequence":"additional","affiliation":[{"name":"Department of Urology Yokohama City University Graduate School of Medicine  Yokohama Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Makiyama","sequence":"additional","affiliation":[{"name":"Department of Urology Yokohama City University Graduate School of Medicine  Yokohama Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15243"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3806-19"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035716"},{"key":"e_1_2_10_5_1","unstructured":"Ministry of Health L Welfare \u201cRevision of Precautions: Lenvatinib Mesilate \u201d(2018)."},{"issue":"8","key":"e_1_2_10_6_1","first-page":"1314","article-title":"A Case of Emergent Surgery For Acute Acalculous Cholecystitis During Lenvatinib Therapy","volume":"84","author":"Sakuma M.","year":"2023","journal-title":"Journal of Japan Surgical Association"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.5106\/jjshns.28.329"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712126"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026982"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603813"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707330"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.121.000828"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0355"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3300-3"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027182"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215536"}],"container-title":["IJU Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/iju5.70203","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/iju5.70203","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/iju5.70203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:46:50Z","timestamp":1785134810000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/iju5.70203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1002\/iju5.70203"],"URL":"https:\/\/doi.org\/10.1002\/iju5.70203","archive":["Portico"],"relation":{},"ISSN":["2577-171X","2577-171X"],"issn-type":[{"value":"2577-171X","type":"print"},{"value":"2577-171X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"2026-03-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70203"}}